← FDA Drug Approvals (Drugs@FDA)

PRIMAXIN

NDA · New Drug Application · Sponsor: MERCK · Approved 1985-11-26

Drug application

FDA Application #

NDA050587

Application type

New Drug Application

Brand name

PRIMAXIN

Generic name

IMIPENEM AND CILASTATIN SODIUM

Active ingredients

CILASTATIN SODIUM; IMIPENEM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

MERCK

Manufacturer

Merck Sharp & Dohme LLC

First approval

1985-11-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown